$PMCB Form 10-K/A

Form 10-K/A for PHARMACYTE BIOTECH, INC. 19-Jan-2016 Annual Report ITEM 7.

$PMCB Receives Orphan Drug Designation

PharmaCyte Biotech Obtains Orphan Drug Designation in Europe for Its Pancre

Marijuana Stocks Gain Traction As March Roars On

For many marijuana stock investors and those looking for marijuana stocks t

$PMCB Initiates Expanded Follow-up Study in the United States on the Accumulation of Malignant Ascites Fluid

PharmaCyte Biotech Initiates Expanded Follow-up Study in the United States

$PMCB International Diabetes Consortium

PharmaCyte Biotech’s International Diabetes Consortium Sets Path Forw

$PMCB Diabetes Treatment and How Will it Work

PharmaCyte Biotech’s Diabetes Treatment: How Would It Work? SAN DIEGO

$PMCB Officially Begins Development of Diabetes Treatment

PharmaCyte Biotech Officially Begins Development of Diabetes Treatment With

$PMCB Partner Austrianova Opens New Facilities in Singapore

PharmaCyte Biotech’s Partner Austrianova Opens New Facilities in Sing

$PMCB Follow-up Study on Malignant Ascites Fluid

PharmaCyte Biotech’s Expanded Follow-up Study on Malignant Ascites Fl